Remarkably, YAP activation has been reported to be associated with stemness [44], conversion of normal fibroblasts to cancer-associated fibroblasts (CAFs) [45], and resistance to BRAF and/or MEK inhibitors [46, 47]. The gene discussed is MAP2K7; the disease is cancer.